{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T16:23:21Z","timestamp":1773332601243,"version":"3.50.1"},"reference-count":16,"publisher":"Japanese Society of Internal Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,5,15]]},"DOI":"10.2169\/internalmedicine.6153-20","type":"journal-article","created":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T22:10:26Z","timestamp":1608588626000},"page":"1611-1614","source":"Crossref","is-referenced-by-count":6,"title":["Aquaporin-4-antibody-positive Neuromyelitis Optica Spectrum Disorder in a Patient with Charcot-Marie-Tooth Disease Type 1A"],"prefix":"10.2169","volume":"60","author":[{"given":"Yuichi","family":"Hamada","sequence":"first","affiliation":[{"name":"Department of Neurology, Teikyo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazusa","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Teikyo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takamichi","family":"Kanbayashi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Teikyo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Hatanaka","sequence":"additional","affiliation":[{"name":"Department of Neurology, Teikyo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Teikyo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Sonoo","sequence":"additional","affiliation":[{"name":"Department of Neurology, Teikyo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Koros C, Evangelopoulos ME, Kilidireas C, et al. Central nervous system demyelination in a Charcot-Marie-Tooth type 1A patient. Case Rep Neurol Med 2013: 243652, 2013.","DOI":"10.1155\/2013\/243652"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Bird TD, Griep E. Pattern reversal visual evoked potentials. Studies in Charcot-Marie-Tooth hereditary neuropathy. Arch Neurol 38: 739-741, 1981.","DOI":"10.1001\/archneur.1981.00510120039003"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Frasson E, Polo A, Di Summa A, et al. Multiple sclerosis associated with duplicated CMT1A: a report of two cases. J Neurol Neurosurg Psychiatry 63: 413-414, 1997.","DOI":"10.1136\/jnnp.63.3.413a"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Almsaddi M, Bertorini TE, Seltzer WK. Demyelinating neuropathy in a patient with multiple sclerosis and genotypical HMSN-1. Neuromuscul Disord 8: 87-89, 1998.","DOI":"10.1016\/S0960-8966(98)00016-9"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Panas M, Karadima G, Kalfakis N, et al. Charcot-Marie-Tooth disease type 1A with central nervous system involvement in two generations. J Neurol 251: 484-485, 2004.","DOI":"10.1007\/s00415-004-0376-5"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Wakerley BR, Harman FE, Altmann DM, et al. Charcot-Marie-Tooth disease associated with recurrent optic neuritis. J Clin Neurosci 18: 1422-1423, 2011.","DOI":"10.1016\/j.jocn.2011.03.003"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Do\u011fan Y, G\u00fcl \u015e, Ceylan AC, et al. A special association between Charcot-Marie-Tooth type 1A disease and relapsing remitting multiple sclerosis. Mult Scler Relat Disord 35: 83-85, 2019.","DOI":"10.1016\/j.msard.2019.07.015"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Garc\u00eda-Est\u00e9vez DA, Cid-Rodr\u00edguez C, Ozaita-Arteche G. Charcot-Marie-Tooth Disease Type 1A and Inflammatory-Demyelinating Lesions in the Central Nervous System. Int J Neurol Neurother 6: 080, 2019.","DOI":"10.23937\/2378-3001\/1410080"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Davies S, Nicholson T, Laura M, et al. Spread of T lymphocyte immune responses to myelin epitopes with duration of multiple sclerosis. J Neuropathol Exp Neurol 64: 371-377, 2005.","DOI":"10.1093\/jnen\/64.5.371"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Greer JM, Pender MP. Myelin proteolipid protein: an effective autoantigen and target of autoimmunity in multiple sclerosis. J Autoimmun 31: 281-287, 2008.","DOI":"10.1016\/j.jaut.2008.04.018"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Anderson TJ, Klugmann M, Thomson CE, et al. Distinct phenotypes associated with increasing dosage of the PLP gene: implication ns for CMT1A due to PMP22 gene duplication. Ann N Y Acad Sci 883: 234-246, 1999.","DOI":"10.1111\/j.1749-6632.1999.tb08585.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Tackenberg B, M\u00f6ller JC, Rindock H, et al. CNS involvement in hereditary neuropathy with pressure palsies (HNPP). Neurology 67: 2250-2252, 2006.","DOI":"10.1212\/01.wnl.0000249185.78359.06"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. H\u00e4usser-Kinzel S, Weber MS. The role of B cells and antibodies in multiple sclerosis, neuromyelitis optica, and related disorders. Front Immunol 10: 201, 2019.","DOI":"10.3389\/fimmu.2019.00201"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Matsuya N, Komori M, Nomura K, et al. Increased T-cell immunity against aquaporin-4 and proteolipid protein in neuromyelitis optica. Int Immunol 23: 565-573, 2011.","DOI":"10.1093\/intimm\/dxr056"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Michalski J-P, Anderson C, Beauvais A, et al. The proteolipid protein promoter drives expression outside of the oligodendrocyte lineage during embryonic and early postnatal development. PLoS One 6: e19772, 2011.","DOI":"10.1371\/journal.pone.0019772"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Sereda MW, Meyer zu, H\u00f6rste G, Suter U, et al. Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A). Nat Med 9: 1533-1537, 2003.","DOI":"10.1038\/nm957"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/10\/60_6153-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T04:04:08Z","timestamp":1621051448000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/10\/60_6153-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,15]]},"references-count":16,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6153-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,15]]}}}